Flagship Pioneering provides $50 mln to Foghorn Therapeutics

Cambridge, Massachusetts-based Foghorn Therapeutics, a developer of therapies for cancer and other serious diseases, has secured $50 million in funding. The investor was Flagship Pioneering.

Source: Press Release